Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 45, 2019 - Issue 6
Submit an article Journal homepage
167
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Novel hypolipidemic conjugates of fatty acid and bile acid with lysine for linkage

Xue-Yuan JinInternational Center for Liver Diseases Treatment, Beijing, China; View further author information
,
Chuan-Bao ZhuState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Shi-Yong FanState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Jia-Lin SunState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; View further author information
,
Yu-Cong ShiCapital Medical University School of Basic Medical Sciences, Beijing, ChinaView further author information
,
Chu-Han WangCapital Medical University School of Basic Medical Sciences, Beijing, ChinaView further author information
,
Hui-Fen WangInternational Center for Liver Diseases Treatment, Beijing, China; View further author information
,
Bo-Hua ZhongState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; Correspondence[email protected]
View further author information
,
Yi-Shan YaoState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; Correspondence[email protected]
View further author information
&
Wei-Guo ShiState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China; Correspondence[email protected]
View further author information
 show all
Pages 995-998 | Received 26 Oct 2018, Accepted 27 Feb 2019, Published online: 20 Mar 2019

References

  • Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113.
  • Vigna GB, Fellin R. Pharmacotherapy of dyslipidemias in the adult population. Expert Opin Pharmacother. 2010;11:3041.
  • Florentin M, Liberopoulos EN, Mikhailidis DP, et al. Emerging options in the treatment of dyslipidemias: a bright future? Expert Opin Emerg Drugs. 2011;16:247.
  • Demyen M, Alkhalloufi K, Pyrsopoulos NT. Lipid-lowering agents and hepatotoxicity. Clin Liver Dis. 2013;17:699.
  • Kostapanos MS, Florentin M, Elisaf MS. Fenofibrate and the kidney: an overview. Eur J Clin Invest. 2013;43:522.
  • Jukema JW, Cannon CP, de Craen AJ, et al. The controversies of statin therapy: weighing the evidence. J Am Coll Cardiol. 2012;60:875.
  • Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113(10):1753–1764.
  • Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 2003;83:633.
  • Enhsen A, Kramer W, Günther Wess. Bile acids in drug discovery. Drug Discov Today, 1998;3(9):409–418.
  • Fiorucci S, Antonelli E, Morelli O, et al. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A. 2001;98:8897.
  • Gilat T, Leikin-Frenkel A, Goldier I, et al. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC). Hepatology. 2003;38:436.
  • Pathil A, Mueller J, Warth A, et al. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Hepatology. 2012;55:1369.
  • Leikin-Frenkel A, Gonen A, Shaish A, et al. Fatty acid bile acid conjugate inhibits hepatic stearoyl coenzyme A desaturase and is non-atherogenic. Arch Med Res. 2010;41:397.
  • Chamulitrat W, Liebisch G, Xu W, et al. Ursodeoxycholyl lysophosphatidylethanolamide inhibits lipoapoptosis by shifting fatty acid pools toward monosaturated and polyunsaturated fatty acids in mouse hepatocytes. Mol Pharmacol. 2013;84:696.
  • Gilat T, Leikin-Frenkel A, Goldiner L, et al. Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice. Lipids 2001;36:1135.
  • Leikin-Frenkel A, Weinbroum AA, Leikin-Gobbi D, et al. Faecal sterol output is increased by arachidyl amido cholanoic acid (Aramchol) in rats. Biochem Soc Trans. 2004;32:131.
  • Eshraghian A. Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23:7495.
  • Safadi R, Konikoff FM, Mahamid M, et al. The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12:2085.
  • Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD/NASH. J Gastroenterol. 2018;53:362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.